- Home
- BDTX vs OXLCO Comparison
BDTX vs OXLCO Comparison
Compare BDTX & OXLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- OXLCO
- Stock Information
- Founded
- BDTX 2014
- OXLCO N/A
- Country
- BDTX United States
- OXLCO United States
- Employees
- BDTX N/A
- OXLCO N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- OXLCO Investment Managers
- Sector
- BDTX Health Care
- OXLCO Finance
- Exchange
- BDTX Nasdaq
- OXLCO Nasdaq
- Market Cap
- BDTX 132.5M
- OXLCO N/A
- IPO Year
- BDTX 2020
- OXLCO N/A
- Fundamental
- Price
- BDTX $2.87
- OXLCO $23.24
- Analyst Decision
- BDTX Strong Buy
- OXLCO
- Analyst Count
- BDTX 6
- OXLCO 0
- Target Price
- BDTX $14.83
- OXLCO N/A
- AVG Volume (30 Days)
- BDTX 1.2M
- OXLCO N/A
- Earning Date
- BDTX 08-05-2025
- OXLCO N/A
- Dividend Yield
- BDTX N/A
- OXLCO N/A
- EPS Growth
- BDTX N/A
- OXLCO N/A
- EPS
- BDTX 0.09
- OXLCO N/A
- Revenue
- BDTX $70,000,000.00
- OXLCO N/A
- Revenue This Year
- BDTX N/A
- OXLCO N/A
- Revenue Next Year
- BDTX N/A
- OXLCO N/A
- P/E Ratio
- BDTX $32.58
- OXLCO N/A
- Revenue Growth
- BDTX N/A
- OXLCO N/A
- 52 Week Low
- BDTX $1.20
- OXLCO N/A
- 52 Week High
- BDTX $6.75
- OXLCO N/A
- Technical
- Relative Strength Index (RSI)
- BDTX 68.91
- OXLCO 56.08
- Support Level
- BDTX $2.43
- OXLCO $23.16
- Resistance Level
- BDTX $2.72
- OXLCO $23.25
- Average True Range (ATR)
- BDTX 0.18
- OXLCO 0.07
- MACD
- BDTX 0.02
- OXLCO -0.00
- Stochastic Oscillator
- BDTX 99.31
- OXLCO 61.11
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About OXLCO Oxford Lane Capital Corp. Preferred Stock Shares 6.00% Series 2029
Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.